Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,640.00
+45.00 (1.25%)
At close: Jul 21, 2026

Yuyu Pharma Revenue

Yuyu Pharma had revenue of 35.54B KRW in the quarter ending March 31, 2026, with 8.01% growth. This brings the company's revenue in the last twelve months to 143.52B, up 8.19% year-over-year. In the year 2025, Yuyu Pharma had annual revenue of 140.88B with 5.81% growth.

Revenue (ttm)
143.52B
Revenue Growth
+8.19%
P/S Ratio
0.40
Revenue / Employee
565.04M
Employees
254
Market Cap
57.32B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025140.88B7.74B5.81%
Dec 31, 2024133.15B-4.06B-2.96%
Dec 31, 2023137.21B-1.67B-1.20%
Dec 31, 2022138.88B23.23B20.08%
Dec 31, 2021115.66B17.54B17.87%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jeil Pharma Holdings625.97B
Ildong Holdings598.69B
HANDOK550.69B
MYUNGMOON Pharm co.,Ltd197.37B
Kukje Pharma177.97B
CKD Bio159.93B
CMG Pharmaceutical110.12B
Aprogen Biologics78.00B
Revenue Rankings